Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis

Heme oxygenase (HO) breaks down the pro-oxidant heme into carbon monoxide, iron and the antioxidant biliverdin. The isoform HO-1 plays an effective role to counteract oxidative damage and to control inflammation. Prolonged cellular damage due to chronic inflammation is one of the reasons leading to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Caballero, F.
Otros Autores: Meiss, R., Gimenez, A., Batlle, A., Vazquez, E.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2004
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 15587caa a22017297a 4500
001 PAPER-21172
003 AR-BaUEN
005 20230518205236.0
008 190411s2004 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-4344599417 
024 7 |2 cas  |a 4 dimethylaminoazobenzene, 60-11-7; biliverdin, 114-25-0; carbon dioxide, 124-38-9, 58561-67-4; iron, 14093-02-8, 53858-86-9, 7439-89-6; Heme Oxygenase (Decyclizing), EC 1.14.99.3; Heme Oxygenase-1, EC 1.14.99.3; Hmox1 protein, mouse, EC 1.14.99.3; Membrane Proteins; p-Dimethylaminoazobenzene, 60-11-7 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a IJEPE 
100 1 |a Caballero, F. 
245 1 0 |a Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis 
260 |c 2004 
270 1 0 |m Batlle, A.Viamonte 1881 100 A, 1056 - Buenos Aires, Argentina; email: batlle@mail.retina.ar 
506 |2 openaire  |e Política editorial 
504 |a Abraham, N., Botros, F., Rezzani, R., Rodella, L., Bianchi, R., Goodman, A., Differential effect of cobalt protoporphyrin on distributions of heme oxygenase in renal structure zand on blood pressure SHR (2002) Cell Mol. Biol., 48, pp. 895-902 
504 |a Abraham, N., Lavrovsky, Y., Schwartzman, M., Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: Protective effect against heme and hemoglobin toxicity (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 6798-6802 
504 |a Ahn, B., Han, B., Kim, D., Ohshima, H., Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumours induced by N-nitrosodiethylamine (1999) Carcinogenesis, 20, pp. 1337-1344 
504 |a Ames, B., Gold, L., Chemical carcinogenesis: Too many rodent carcinogens (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 7772-7776 
504 |a Batlle, A., Porphyrins, porphyrias, cancer and photodynamic therapy - A model of Carcinogenesis (1993) J. Photochem. Photobiol. B., 20, pp. 5-22 
504 |a Boone, C., Kelloff, G., Steele, V., Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy (1992) Cancer Res., 52, pp. 1651-1659 
504 |a Braun, L., Mikumo, R., Fauston, N., Production of hepatocellular carcinoma by oval cells: Cell cycle expression of c-myc and p53 at different stages of oval cell transformation (1989) Cancer Res., 49, pp. 1554-1561 
504 |a Butterworth, B., Goldsworthy, T., The role of cell proliferation in multistage carcinogenesis (1991) Proc. Soc. Exp. Biol. Med., 198, pp. 683-687 
504 |a Caballero, F., Gerez, E., Batlle, A., Vazquez, E., Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation (2002) Br. J. Cancer, 86, pp. 630-635 
504 |a Caballero, F., Gerez, E., Oliveri, L., Falcoff, N., Batlle, A., Vazquez, E., On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice (2001) Int. J. Biochem. Cell Biol., 33, pp. 681-690 
504 |a Camhi, S., Lee, P., Choi, A., The oxidative stress response (1995) New Horiz., 3, pp. 170-182 
504 |a Chiu, H., Brittingham, J., Laskin, D., Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: Effects of hemin and biliverdin (2002) Toxicol. Appl. Pharmacol., 181, pp. 106-115 
504 |a Clark, J., Foresti, R., Green, C., Motterlini, R., Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress (2000) Biochem. J., 348, pp. 615-619 
504 |a Doi, K., Akaike, T., Fujii, S., Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth (1999) Br. J. Cancer, 80, pp. 945-954 
504 |a Dominguez-Malagón, H., Gaytan-Graham, M., Hepatocellular carcinoma: An update (2001) Ultrastruct. Pathol., 25, pp. 497-516 
504 |a Dulak, J., Jozkowicz, A., Foresti, R., Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells (2002) Antioxid. Redox Signal., 4, pp. 229-240 
504 |a Farber, E., Similarities in the sequence of early histologic changes induced in the livers of rats by ethionine, 2-acetylaminofluorene and 3′methyl-4- dimethylaminoazobenzene (1956) Cancer Res., 16, pp. 142-148 
504 |a Farber, E., Some emerging general principles in the pathogenesis of hepatocellular carcinoma (1986) Cancer Surv., 5, pp. 698-718 
504 |a Foresti, R., Motterlini, R., The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis (1999) Free Radic. Res., 31, pp. 459-475 
504 |a Frith, C., Ward, J., Turusov, V., Tumours of the liver: Tumours of the mouse (1994) Pathology of Tumours in Laboratory Animals, 2, pp. 223-269. , (eds. V. Turusov, U. Mohr). Lyon: IARC Scientific Publications No. 111, International Agency for Research on Cancer 
504 |a Gerez, E., Caballero, F., Vazquez, E., Polo, C., Batlle, A., Hepatic enzymatic metabolism alterations and oxidative stress during the onset of carcinogenesis: Protective role of alpha-tocopherol (1998) Eur. J. Cancer Prev., 7, pp. 69-76 
504 |a Gerez, E., Vazquez, E., Caballero, F., Polo, C., Batlle, A., Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: Effect of veronal (1997) Gen. Pharmacol., 29, pp. 569-573 
504 |a Gourny, J., Auvigne, I., Pichard, V., Ligeza, C., Bralet, M., Ferry, N., In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: Evidence for dedifferentiation of mature hepatocytes (2002) Lab. Invest., 82, pp. 781-788 
504 |a Klaunig, J., Xu, Y., Isenberg, J., The role of oxidative stress in chemical carcinogenesis (1998) Environ. Health Perspect., 106, pp. 289-295 
504 |a Maines, M., The heme oxygenase system: A regulator of second messenger gases (1997) Annu. Rev. Pharmacol. Toxicol., 37, pp. 517-554 
504 |a Maines, M., The heme oxygenase system and its functions in the brain (2000) Cell Mol. Biol., 46, pp. 573-585 
504 |a Motterlini, R., Foresti, R., Bassi, R., Green, C., Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress (2000) Free Radic. Biol. Med., 28, pp. 1303-1312 
504 |a Motterlini, R., Gonzales, A., Foresti, R., Clark, J., Green, C., Winslow, R., Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo (1998) Circ. Res., 83, pp. 568-577 
504 |a Motterlini, R., Green, C., Foresti, R., Regulation of heme oxygenase-1 by redox signals involving nitric oxide (2002) Antioxid. Redox Signal., 4, pp. 615-624 
504 |a Naughton, P., Hoque, M., Green, C., Foresti, R., Motterlini, R., Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: Involvement of the transcription factor Nrf2 (2002) Cell Mol. Biol., 48, pp. 885-894 
504 |a Nishie, A., Ono, M., Shono, T., Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas (1999) Clin. Cancer Res., 5, pp. 1107-1113 
504 |a Ohshima, H., Bartsch, H., Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis (1994) Mutat. Res., 305, pp. 253-264 
504 |a Otterbein, L., Choi, A., Heme oxygenase: Colors of defense against cellular stress (2000) Am. J. Physiol. Lung Cell Mol. Physiol., 279, pp. L1029 
504 |a Pitot, H., Dragan, Y., Facts and theories concerning the mechanisms of carcinogenesis (1991) FASEB J., 5, pp. 2280-2286 
504 |a Pitot, H., Dragan, Y., Sargent, L., Xu, Y., Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat (1991) Environ. Health Perspect., 93, pp. 181-189 
504 |a Pitot, H., Dragan, Y., Teeguarden, J., Hsia, S., Campbell, H., Quantitation of multistage carcinogenesis in rat liver (1996) Toxicol. Pathol., 24, pp. 119-128 
504 |a Poss, K., Tonegawa, S., Heme oxygenase 1 is required for mammalian iron reutilization (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 10919-10924 
504 |a Saeter, G., Seglen, P., Cell biology of hepatocarcinogenesis (1990) Crit. Rev. Oncog., 1, pp. 437-466 
504 |a Seo, M., Lynch, K., Podolsky, D., Multiplicity of transforming growth factors in human malignant effusions (1988) Cancer Res., 48, pp. 1792-1797 
504 |a Tanaka, S., Akaike, T., Fang, J., Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour (2003) Br. J. Cancer, 88, pp. 902-909 
504 |a Tomaro, M., Batlle, A., Bilirubin: Its role cytoprotection against oxidative stress (2002) Int. J. Biochem. Cell Biol., 34, pp. 216-220 
504 |a Tsuji, M., Yanagawa, T., Iwasa, S., Heme oxygenase-1 expression in oral squamous cell carcinoma is involved in lymph node metastasis (1999) Cancer Lett., 138, pp. 53-59 
504 |a Vazquez, E., Gerez, E., Caballero, F., On the promoting action of tamoxifen in the p-dimethylaminoazobenzene induced hepatocarcinogenesis CF1 mice model and the cytoprotective role of heme oxygenase (2002) Heme Oxygenase in Biology and Medicine, pp. 469-479. , (eds. N. Abraham, J. Alam, K. Nath). New York: Kluwer Academic Plenum Publishers 
504 |a Wagener, F., Eggert, A., Boerman, O., Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase (2001) Blood, 98, pp. 1802-1811 
504 |a Wagener, F., Feldman, E., De Witte, T., Abraham, N., Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells (1997) Proc. Soc. Exp. Biol. Med., 216, pp. 456-463 
504 |a Wang, L., Lee, T., Lee, F., Pai, R., Chau, L., Expression of heme oxygenase 1 in atherosclerotic lesions (1998) Am. J. Pathol., 152, pp. 711-720 
504 |a Willis, D., Moore, A., Frederick, R., Willoughby, D., Heme oxygenase: A novel target for the modulation of the inflammatory response (1996) Nat. Med., 2, pp. 87-90 
504 |a Workman, P., Twentyman, P., Balkwill, F., United Kingdom Co-Ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition) (1998) Br. J. Cancer, 77, pp. 1-10 
504 |a Yang, L., Quan, S., Abraham, N., Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury (1999) Am. J. Physiol., 277, pp. L127 
520 3 |a Heme oxygenase (HO) breaks down the pro-oxidant heme into carbon monoxide, iron and the antioxidant biliverdin. The isoform HO-1 plays an effective role to counteract oxidative damage and to control inflammation. Prolonged cellular damage due to chronic inflammation is one of the reasons leading to the development of tumours. The aim of this work was to investigate HO-1 expression and localization along the different stages of chemically induced hepatocarcinogenesis (HCC) and the occurring morphological changes. To provoke sustained oxidative stress and chronic inflammation, CF1 mice received dietary p-dimethylaminoazobenzene (DAB, 0.5%, w/w) during a whole period of 14 months. HO-1 expression increased along the experimental trial in morphologically normal hepatocytes in DAB-treated animals. HO-1 expression diminished in altered hepatic foci (AHF) and oval cells and early preneoplastic lesions. Otherwise, marked HO-1 overexpression was detected in Kupffer cells and macrophages surrounding necrotic and nodular areas. Adenomas showed decreased HO-1 immunostaining. In hepatocellular carcinomas, an inverse relationship was found between the immunohistochemical expression of HO-1 and the degree of tumour differentiation, being negative in poorly differentiated tumours. In our experimental model, down modulation of HO-1 expression correlated with malignancy progression. Thus, our data point to activation of HO-1 as a potential therapeutic tool.  |l eng 
593 |a Ctro. Invest. Sobre Porfirinas P., Depto. de Quim. Biologica, UBA - Ciudad Universitaria, Buenos Aires, Argentina 
593 |a Departamento de Patología, Inst. de Estudios Oncológicos, Academia Nacional de Medicina, Buenos Aires, Argentina 
593 |a Viamonte 1881 100 A, 1056 - Buenos Aires, Argentina 
690 1 0 |a HEME OXYGENASE 
690 1 0 |a HEPATOCARCINOGENESIS 
690 1 0 |a INFLAMMATION 
690 1 0 |a OXIDATIVE STRESS 
690 1 0 |a P-DIMETHYLAMINOAZOBENZENE 
690 1 0 |a 4 DIMETHYLAMINOAZOBENZENE 
690 1 0 |a ANTIOXIDANT 
690 1 0 |a BILIVERDIN 
690 1 0 |a CARBON DIOXIDE 
690 1 0 |a HEME OXYGENASE 1 
690 1 0 |a IRON 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CELL DAMAGE 
690 1 0 |a CELL PROLIFERATION 
690 1 0 |a CHEMICAL CARCINOGENESIS 
690 1 0 |a CHRONIC INFLAMMATION 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DISEASE COURSE 
690 1 0 |a ENZYME LOCALIZATION 
690 1 0 |a EPITHELIUM CELL 
690 1 0 |a IMMUNOHISTOCHEMISTRY 
690 1 0 |a INFLAMMATION 
690 1 0 |a KUPFFER CELL 
690 1 0 |a LIVER ADENOMA 
690 1 0 |a LIVER CARCINOGENESIS 
690 1 0 |a LIVER CELL 
690 1 0 |a LIVER CELL CARCINOMA 
690 1 0 |a LIVER INJURY 
690 1 0 |a LIVER NECROSIS 
690 1 0 |a MACROPHAGE 
690 1 0 |a MALE 
690 1 0 |a MORPHOLOGICAL TRAIT 
690 1 0 |a MOUSE STRAIN 
690 1 0 |a NEOPLASM 
690 1 0 |a NONHUMAN 
690 1 0 |a OXIDATION 
690 1 0 |a OXIDATIVE STRESS 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a RAT 
690 1 0 |a TUMOR DIFFERENTIATION 
690 1 0 |a WESTERN BLOTTING 
690 1 0 |a ADENOMA 
690 1 0 |a ANIMALS 
690 1 0 |a BLOTTING, WESTERN 
690 1 0 |a CARCINOMA, HEPATOCELLULAR 
690 1 0 |a DISEASE PROGRESSION 
690 1 0 |a HEME OXYGENASE (DECYCLIZING) 
690 1 0 |a HEME OXYGENASE-1 
690 1 0 |a HEPATOCYTES 
690 1 0 |a IMMUNOENZYME TECHNIQUES 
690 1 0 |a LIVER 
690 1 0 |a LIVER NEOPLASMS 
690 1 0 |a MACROPHAGES 
690 1 0 |a MALE 
690 1 0 |a MEMBRANE PROTEINS 
690 1 0 |a MICE 
690 1 0 |a MICE, INBRED STRAINS 
690 1 0 |a P-DIMETHYLAMINOAZOBENZENE 
690 1 0 |a PRECANCEROUS CONDITIONS 
650 1 7 |2 spines  |a NECROSIS 
700 1 |a Meiss, R. 
700 1 |a Gimenez, A. 
700 1 |a Batlle, A. 
700 1 |a Vazquez, E. 
773 0 |d 2004  |g v. 85  |h pp. 213-221  |k n. 4  |p Int. J. Exp. Pathol.  |x 09599673  |w (AR-BaUEN)CENRE-5248  |t International Journal of Experimental Pathology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-4344599417&doi=10.1111%2fj.0959-9673.2004.00391.x&partnerID=40&md5=478f30bafd0f6371f7663df99bd77e55  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1111/j.0959-9673.2004.00391.x  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_09599673_v85_n4_p213_Caballero  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09599673_v85_n4_p213_Caballero  |y Registro en la Biblioteca Digital 
961 |a paper_09599673_v85_n4_p213_Caballero  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 82125